Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.

Human pathology - 1 Feb 2015

Piris Adriano, Mihm Martin C, Hoang Mai P

Abstract excerpt

BAP1 (BRCA1-associated protein 1) is a tumor suppressor gene whose mutations have recently been reported to increase susceptibility for the development of uveal melanoma, cutaneous atypical and epithelioid melanocytic lesions, clear cell renal cell carcinoma, and other tumors. Screening for BAP1 mutation/loss/inactivation and BRAFV600E mutation can be done by immunohistochemistry. We investigated BAP1 and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to Cell Proliferation
Share to Immunohistochemistry

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Melanoma

Share to Mutation

Share to Proto-Oncogene Proteins B-raf

Share to Tumor Suppressor Proteins

Share to Ubiquitin Thiolesterase

Source

Identifiers

PMID: 25479927
DOI: 10.1016/j.humpath.2014.10.015

Genes

BAP1
BRCA1

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

BAP1 and BRAFV600E expression in benign and malignant melanocytic proliferations.PMID 25479927Read ↗

Tumours associated with BAP1 mutations.Semantic proximity Read ↗

A distinct subset of atypical Spitz tumors is characterized by BRAF mutation and loss of BAP1 expression.Semantic proximity Read ↗

Melanoma With Loss of BAP1 Expression in Patients With No Family History of BAP1-Associated Cancer Susceptibility Syndrome: A Case SeriesSemantic proximity Read ↗

BRCA1‐associated protein (BAP1)‐inactivated melanocytic tumorsSemantic proximity Read ↗

Multiple Epithelioid Spitz Nevi or Tumors With Loss of BAP1 ExpressionSemantic proximity Read ↗

Histomorphologic spectrum of BAP1 negative melanocytic neoplasms in a family with BAP1-associated cancer susceptibility syndrome.Semantic proximity Read ↗

Multiple Cutaneous Melanomas and Clinically Atypical Moles in a Patient With a Novel Germline BAP1 Mutation.Semantic proximity Read ↗

Loss of BAP1 Expression in Basal Cell Carcinomas in Patients With Germline BAP1 Mutations.Semantic proximity Read ↗

Gene Expression and Mutational Profile in BAP-1 Inactivated Melanocytic Lesions of Progressive Malignancy from a Patient with Multiple Lesions.Semantic proximity Read ↗

BAP1-deficient and VE1-negative atypical Spitz tumor.Semantic proximity Read ↗

The elusive BAP1 mutation in pediatric melanocytic tumors.Semantic proximity Read ↗

Genotypic and Phenotypic Features of BAP1 Cancer Syndrome: A Report of 8 New Families and Review of Cases in the Literature.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.